- Home
- CNEY vs ADIL Comparison
CNEY vs ADIL Comparison
Compare CNEY & ADIL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CNEY | ADIL |
|---|---|---|
| Founded | 2009 | 2010 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Major Chemicals | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.7M | 6.4M |
| IPO Year | 2019 | 2017 |
Fundamental Metrics
Financial Performance| Metric | CNEY | ADIL |
|---|---|---|
| Price | $0.82 | $1.64 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $37.50 |
| AVG Volume (30 Days) | ★ 136.1K | 97.6K |
| Earning Date | 01-01-0001 | 06-10-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.11 | $0.13 |
| 52 Week High | $3.25 | $3.67 |
Technical Indicators
Market Signals| Indicator | CNEY | ADIL |
|---|---|---|
| Relative Strength Index (RSI) | 38.56 | 44.31 |
| Support Level | $0.54 | $0.28 |
| Resistance Level | $1.10 | $3.67 |
| Average True Range (ATR) | 0.10 | 0.27 |
| MACD | -0.03 | -0.17 |
| Stochastic Oscillator | 10.22 | 12.27 |
Price Performance
Historical ComparisonAbout CNEY CN Energy Group Inc.
CN Energy Group Inc along with its subsidiaries is a manufacturer and supplier of wood-based activated carbon that is used in pharmaceutical manufacturing, industrial manufacturing, water purification, environmental protection, and food and beverage production and a producer of biomass electricity generated in the process of producing activated carbon. The firm generates a majority of its revenue from Activated carbon.
About ADIL Adial Pharmaceuticals Inc
Adial Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company develops prescription medications for addiction and related disorders. Its lead product is AD04, which is for the treatment of alcohol use disorder. The active ingredient in AD04 is ondansetron, a serotonin-3 antagonist.